BGMS
Price
$4.04
Change
+$0.23 (+6.04%)
Updated
Oct 17 closing price
Capitalization
11.87M
Intraday Buy/Sell Signals
KAPA
Price
$1.16
Change
-$0.01 (-0.85%)
Updated
Oct 17 closing price
Capitalization
24.06M
46 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

BGMS vs KAPA

Header iconBGMS vs KAPA Comparison
Open Charts BGMS vs KAPABanner chart's image
Bio Green Med Solution
Price$4.04
Change+$0.23 (+6.04%)
Volume$116.72K
Capitalization11.87M
Kairos Pharma
Price$1.16
Change-$0.01 (-0.85%)
Volume$249.16K
Capitalization24.06M
BGMS vs KAPA Comparison Chart in %
BGMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KAPA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BGMS vs. KAPA commentary
Oct 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BGMS is a Hold and KAPA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 18, 2025
Stock price -- (BGMS: $4.04 vs. KAPA: $1.16)
Brand notoriety: BGMS and KAPA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BGMS: 35% vs. KAPA: 20%
Market capitalization -- BGMS: $11.87M vs. KAPA: $24.06M
BGMS [@Biotechnology] is valued at $11.87M. KAPA’s [@Biotechnology] market capitalization is $24.06M. The market cap for tickers in the [@Biotechnology] industry ranges from $106.87B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BGMS’s FA Score shows that 0 FA rating(s) are green whileKAPA’s FA Score has 1 green FA rating(s).

  • BGMS’s FA Score: 0 green, 5 red.
  • KAPA’s FA Score: 1 green, 4 red.
According to our system of comparison, both BGMS and KAPA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BGMS’s TA Score shows that 5 TA indicator(s) are bullish while KAPA’s TA Score has 2 bullish TA indicator(s).

  • BGMS’s TA Score: 5 bullish, 3 bearish.
  • KAPA’s TA Score: 2 bullish, 8 bearish.
According to our system of comparison, BGMS is a better buy in the short-term than KAPA.

Price Growth

BGMS (@Biotechnology) experienced а -21.25% price change this week, while KAPA (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.56%. For the same industry, the average monthly price growth was +15.88%, and the average quarterly price growth was +79.09%.

Reported Earning Dates

KAPA is expected to report earnings on Dec 03, 2025.

Industries' Descriptions

@Biotechnology (+1.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KAPA($24.1M) has a higher market cap than BGMS($11.9M). BGMS YTD gains are higher at: 974.468 vs. KAPA (-23.684).
BGMSKAPABGMS / KAPA
Capitalization11.9M24.1M49%
EBITDAN/A-4.42M-
Gain YTD974.468-23.684-4,114%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A3.03M-
Total DebtN/A142K-
FUNDAMENTALS RATINGS
BGMS: Fundamental Ratings
BGMS
OUTLOOK RATING
1..100
22
VALUATION
overvalued / fair valued / undervalued
1..100
66
Overvalued
PROFIT vs RISK RATING
1..100
94
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BGMSKAPA
RSI
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 5 days ago
67%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
88%
Bearish Trend 1 day ago
89%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 11 days ago
83%
Bullish Trend 5 days ago
90%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 1 day ago
86%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BGMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KAPA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BCBP7.920.09
+1.15%
BCB Bancorp
IMVT17.510.10
+0.57%
Immunovant
RHLD79.830.38
+0.48%
Resolute Holdings Management
AFRM67.90-1.17
-1.69%
Affirm Holdings
LYRA6.90-0.25
-3.47%
Lyra Therapeutics Inc

BGMS and

Correlation & Price change

A.I.dvisor indicates that over the last year, BGMS has been loosely correlated with MIRM. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if BGMS jumps, then MIRM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BGMS
1D Price
Change %
BGMS100%
+6.04%
MIRM - BGMS
36%
Loosely correlated
-1.20%
BRNS - BGMS
31%
Poorly correlated
-1.33%
ORMP - BGMS
30%
Poorly correlated
-1.76%
IMMP - BGMS
27%
Poorly correlated
-1.43%
RNAC - BGMS
26%
Poorly correlated
-4.35%
More

KAPA and

Correlation & Price change

A.I.dvisor indicates that over the last year, KAPA has been loosely correlated with PHIO. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if KAPA jumps, then PHIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KAPA
1D Price
Change %
KAPA100%
-0.85%
PHIO - KAPA
47%
Loosely correlated
-0.47%
SLRX - KAPA
36%
Loosely correlated
-3.29%
AZTR - KAPA
35%
Loosely correlated
-2.41%
GDTC - KAPA
26%
Poorly correlated
+1.78%
BGMS - KAPA
23%
Poorly correlated
+6.04%
More